VERTEX PHARMACEUTICALS INC / MA (VRTX) Gross profit 2016–2025
VERTEX PHARMACEUTICALS INC / MA (VRTX) annual gross profit history from SEC filings — each fiscal year as reported.
$10.3BFY2025 · since FY2016: $1.5B → $10.3B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $10.3B | +9.1% |
| FY2024 | $9.5B | +10.3% |
| FY2023 | $8.6B | +9.6% |
| FY2022 | $7.9B | +17.7% |
| FY2021 | $6.7B | +22.0% |
| FY2020 | $5.5B | +51.3% |
| FY2019 | $3.6B | +37.0% |
| FY2018 | $2.6B | +19.2% |
| FY2017 | $2.2B | +48.4% |
| FY2016 | $1.5B | — |
Source: SEC XBRL filings · For reference only · Not investment advice